November was an eventful month for financial markets, with the outcome of the US presidential election prompting significant intra-month volatility and an acceleration of the correction in bond markets.
October was a challenging month for the fund, with concerns about the prospect of a Clinton victory in the US presidential elections weighing negatively on sentiment towards health care stocks.
I have been an investor in the pharmaceutical industry for most of my career and have for a long time been fascinated by the opportunity for innovation in this sector to not only benefit society but, in turn, deliver great returns to shareholders.
The UK stock market posted a small negative return during July. Having moved broadly sideways all year so far, the market took a nervous step downwards in the last couple of days of July…
Neil has been very careful in building a portfolio that avoids sectors that he believes are vulnerable to a faltering global economy. There is significant emphasis on the tobacco and pharmaceutical sectors.